U.Va. Cancer Initiative Invests $300,000 in Public-Private Research Partnerships

The projects were selected by the initiative’s nine-person review committee, which includes Max Wallace, CEO of Accelerate Brain Cancer Cure.

The University of Virginia’s Cancer Center Technology Partnership Initiative has awarded funding to three projects bringing University and industry researchers together to accelerate treatments for brain, breast and pancreatic cancers.

Launched earlier this year, the initiative is designed to spur collaboration between U.Va. innovators and Virginia-based technology companies to advance cancer research, treatment and statewide economic development.

“As an engine for scientific discovery, the Cancer Center is working to optimize its dual roles in fostering not only a healthy citizenry, but also a healthy economy,” said Michael J. Weber, director of the U.Va. Cancer Center.

The projects were selected by the initiative’s nine-person review committee, which includes Max Wallace, CEO of Accelerate Brain Cancer Cure Inc., and Bill Wofford, partner at the Hutchison Law Group, and several U.Va. researchers and administrators.

“I am honored to be included as part of the U.Va. Cancer Center Technology Partnership Initiative, a unique and visionary approach to fostering the type of public-private partnerships that can help make our investment in academic research come to life,” Wallace said.

“This program will not only help patients, but it will also drive the growth of the innovation-centered businesses that are so important to our new economy. The proposals and presentations that we saw were truly excellent, and I am pleased that the very best of these will be moved forward even more powerfully with the help of these grants.”

For more information, please click here to access the full news release from the Marketing and Communications Office of UVA Innovation.

Share |
October 21, 2014 09:33 PM
ABC2 CEO Max Wallace chaired the gathering of NCI experts and cancer advocates.
October 15, 2014 12:44 PM
Principal Investigators, based in the state of Florida, are invited to apply. Proposal deadline: December 15, 2014. 
October 14, 2014 12:50 PM
ABC2 funds project between UC San Diego Health System and Regulus Therapeutics Inc.

Join us in our fight for a cure!

Twitter